Monoaminergic and Histaminergic Strategies and Treatments in Brain Diseases
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Monoaminergic and Histaminergic Strategies and Treatments in Brain Diseases
Authors
Keywords
-
Journal
Frontiers in Neuroscience
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2016-11-24
DOI
10.3389/fnins.2016.00541
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Monoaminergic neuropathology in Alzheimer’s disease
- (2017) Goran Šimić et al. PROGRESS IN NEUROBIOLOGY
- Expanding the repertoire of L-DOPA’s actions: A comprehensive review of its functional neurochemistry
- (2017) Philippe De Deurwaerdère et al. PROGRESS IN NEUROBIOLOGY
- Serotonergic modulation of the activity of mesencephalic dopaminergic systems: Therapeutic implications
- (2017) Philippe De Deurwaerdère et al. PROGRESS IN NEUROBIOLOGY
- Plaque Deposition Dependent Decrease in 5-HT2A Serotonin Receptor in AβPPswe/PS1dE9 Amyloid Overexpressing Mice
- (2017) Peter Holm et al. JOURNAL OF ALZHEIMERS DISEASE
- The acute and long-term L-DOPA effects are independent from changes in the activity of dorsal raphe serotonergic neurons in 6-OHDA lesioned rats
- (2016) C Miguelez et al. BRITISH JOURNAL OF PHARMACOLOGY
- Piribedil for the Treatment of Motor and Non-motor Symptoms of Parkinson Disease
- (2016) Santiago Perez-Lloret et al. CNS DRUGS
- Serotonergic Drugs: Agonists/Antagonists at Specific Serotonergic Subreceptors for the Treatment of Cognitive, Depressant and Psychotic Symptoms in Alzheimer's Disease
- (2016) Felix-Martin Werner et al. CURRENT PHARMACEUTICAL DESIGN
- Pimavanserin: First Global Approval
- (2016) Anthony Markham DRUGS
- Psychosis in Parkinson’s Disease: Epidemiology, Pathophysiology, and Management
- (2016) Anna Chang et al. DRUGS
- L-DOPA elicits non-vesicular releases of serotonin and dopamine in hemiparkinsonian rats in vivo
- (2016) Cristina Miguelez et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Weight management in obesity - past and present
- (2016) D. Haslam INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Efficacy of rasagiline in early Parkinson's disease: a meta-analysis of data from the TEMPO and ADAGIO studies
- (2016) Robert A. Hauser et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- A Randomized, Double-Blind, Placebo-Controlled Pilot Study of Betahistine to Counteract Olanzapine-Associated Weight Gain
- (2016) Nir Barak et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Association between polymorphism of COMT gene (Val158Met) with Alzheimer's disease: An updated analysis
- (2016) Weiqian Yan et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Schizophrenia
- (2016) Michael J Owen et al. LANCET
- The histaminergic system as a target for the prevention of obesity and metabolic syndrome
- (2016) Gustavo Provensi et al. NEUROPHARMACOLOGY
- Differential control of dopamine ascending pathways by serotonin 2B receptor antagonists: New opportunities for the treatment of schizophrenia
- (2016) Céline Devroye et al. NEUROPHARMACOLOGY
- The novel 5-HT 1A receptor agonist, NLX-112 reduces l -DOPA-induced abnormal involuntary movements in rat: A chronic administration study with microdialysis measurements
- (2016) Andrew C. McCreary et al. NEUROPHARMACOLOGY
- Molecular biomarkers of depression
- (2016) Anand Gururajan et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- New therapeutic opportunities for 5-HT2C receptor ligands in neuropsychiatric disorders
- (2016) Giuseppe Di Giovanni et al. PHARMACOLOGY & THERAPEUTICS
- Current drug treatments targeting dopamine D3 receptor
- (2016) Gian Marco Leggio et al. PHARMACOLOGY & THERAPEUTICS
- Antidepressant drug action — From rapid changes on network function to network rewiring
- (2016) Tomi Rantamäki et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Polypharmacology of dopamine receptor ligands
- (2016) S. Butini et al. PROGRESS IN NEUROBIOLOGY
- A prospective, longitudinal study of platelet serotonin and plasma brain-derived neurotrophic factor concentrations in major depression: effects of vortioxetine treatment
- (2016) Marina Sagud et al. PSYCHOPHARMACOLOGY
- Monoaminergic Mechanisms in Epilepsy May Offer Innovative Therapeutic Opportunity for Monoaminergic Multi-Target Drugs
- (2016) Dubravka Svob Strac et al. Frontiers in Neuroscience
- Serotonin: A New Hope in Alzheimer’s Disease?
- (2015) Sylvie Claeysen et al. ACS Chemical Neuroscience
- Therapeutic Potential of 5-HT2C Receptor Agonists for Addictive Disorders
- (2015) Guy A. Higgins et al. ACS Chemical Neuroscience
- Serotonergic Regulation of Prefrontal Cortical Circuitries Involved in Cognitive Processing: A Review of Individual 5-HT Receptor Mechanisms and Concerted Effects of 5-HT Receptors Exemplified by the Multimodal Antidepressant Vortioxetine
- (2015) Steven C. Leiser et al. ACS Chemical Neuroscience
- The Clinical Discovery of Imipramine
- (2015) Walter A. Brown et al. AMERICAN JOURNAL OF PSYCHIATRY
- Effect of selective and non-selective serotonin receptor activation on l-DOPA-induced therapeutic efficacy and dyskinesia in parkinsonian rats
- (2015) E. Tronci et al. BEHAVIOURAL BRAIN RESEARCH
- Serotonin controlling feeding and satiety
- (2015) Jörg-Peter Voigt et al. BEHAVIOURAL BRAIN RESEARCH
- Emerging mechanisms and treatments for depression beyond SSRIs and SNRIs
- (2015) Elena Dale et al. BIOCHEMICAL PHARMACOLOGY
- Could the serotonin theory give rise to a treatment for levodopa-induced dyskinesia in Parkinson’s disease?
- (2015) Erwan Bezard et al. BRAIN
- Eltoprazine counteracts l-DOPA-induced dyskinesias in Parkinson’s disease: a dose-finding study
- (2015) Per Svenningsson et al. BRAIN
- Protective effect of the multitarget compound DPH-4 on human SSAO/VAP-1-expressing hCMEC/D3 cells under oxygen-glucose deprivation conditions: anin vitroexperimental model of cerebral ischaemia
- (2015) P Sun et al. BRITISH JOURNAL OF PHARMACOLOGY
- Multitarget Therapeutic Leads for Alzheimer’s Disease: Quinolizidinyl Derivatives of Bi- and Tricyclic Systems as Dual Inhibitors of Cholinesterases and β-Amyloid (Aβ) Aggregation
- (2015) Michele Tonelli et al. ChemMedChem
- The 5-HT4Agonist Prucalopride Stimulates L-DOPA-Induced Dopamine Release in Restricted Brain Regions of the Hemiparkinsonian RatIn Vivo
- (2015) Sylvia Navailles et al. CNS Neuroscience & Therapeutics
- Modes and nodes explain the mechanism of action of vortioxetine, a multimodal agent (MMA): blocking 5HT3 receptors enhances release of serotonin, norepinephrine, and acetylcholine
- (2015) Stephen M. Stahl CNS SPECTRUMS
- A review of the current nomenclature for psychotropic agents and an introduction to the Neuroscience-based Nomenclature
- (2015) Joseph Zohar et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- 60 years of advances in neuropsychopharmacology for improving brain health, renewed hope for progress
- (2015) Mark J. Millan et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Connectomics: A new paradigm for understanding brain disease
- (2015) Alex Fornito et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Developments in the field of antidepressants, where do we go now?
- (2015) Francesc Artigas EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Learning from the past and looking to the future: Emerging perspectives for improving the treatment of psychiatric disorders
- (2015) Mark J. Millan et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- NLX-112, a novel 5-HT 1A receptor agonist for the treatment of l -DOPA-induced dyskinesia: Behavioral and neurochemical profile in rat
- (2015) H. Iderberg et al. EXPERIMENTAL NEUROLOGY
- The ABC's of dopamine receptor partial agonists - aripiprazole, brexpiprazole and cariprazine: the 15-min challenge to sort these agents out
- (2015) L. Citrome INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Effects of the beta-adrenergic receptor antagonist Propranolol on dyskinesia and L-DOPA-induced striatal DA efflux in the hemi-parkinsonian rat
- (2015) Nirmal Bhide et al. JOURNAL OF NEUROCHEMISTRY
- A cross-talk between Aβ and endothelial SSAO/VAP-1 accelerates vascular damage and Aβ aggregation related to CAA-AD
- (2015) Montse Solé et al. NEUROBIOLOGY OF AGING
- Elements toward novel therapeutic targeting of the adrenergic system
- (2015) Abdelaziz Ghanemi et al. NEUROPEPTIDES
- Effect of serotonin transporter blockade on L-DOPA-induced dyskinesia in animal models of Parkinson’s disease
- (2015) C. Fidalgo et al. NEUROSCIENCE
- Vortioxetine, a novel antidepressant with multimodal activity: Review of preclinical and clinical data
- (2015) Connie Sanchez et al. PHARMACOLOGY & THERAPEUTICS
- Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease
- (2015) Matthieu F. Bastide et al. PROGRESS IN NEUROBIOLOGY
- Parkinson's disease treatment may cause impulse-control disorder via dopamine D3 receptors
- (2015) Philip Seeman SYNAPSE
- Role of Astrocytes in Epilepsy
- (2015) D. A. Coulter et al. Cold Spring Harbor Perspectives in Medicine
- Serotonergic antidepressant drugs and L-dopa-induced dyskinesias in Parkinson's disease
- (2014) S. Mazzucchi et al. ACTA NEUROLOGICA SCANDINAVICA
- Noradrenergic Terminals Regulatel-DOPA-derived Dopamine Extracellular Levels in a Region-dependent Manner in Parkinsonian Rats
- (2014) Sylvia Navailles et al. CNS Neuroscience & Therapeutics
- Multi-Target Directed Drugs: A Modern Approach for Design of New Drugs for the treatment of Alzheimer’s Disease
- (2014) Kris Simone Tranches Dias et al. Current Neuropharmacology
- Serotonergic Therapies for Cognitive Symptoms in Alzheimer’s Disease: Rationale and Current Status
- (2014) Maria J. Ramirez et al. DRUGS
- Negative symptoms of schizophrenia: Clinical characteristics, pathophysiological substrates, experimental models and prospects for improved treatment
- (2014) Mark J. Millan et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Fluoxetine: a case history of its discovery and preclinical development
- (2014) Laura Perez-Caballero et al. Expert Opinion on Drug Discovery
- A 6-week randomized, double-blind, placebo-controlled, comparator referenced trial of vabicaserin in acute schizophrenia
- (2014) Joan H.Q. Shen et al. JOURNAL OF PSYCHIATRIC RESEARCH
- From Chemotherapy-Induced Emesis to Neuroprotection: Therapeutic Opportunities for 5-HT3 Receptor Antagonists
- (2014) Gohar Fakhfouri et al. MOLECULAR NEUROBIOLOGY
- Four pioneers of L-dopa treatment: Arvid Carlsson, Oleh Hornykiewicz, George Cotzias, and Melvin Yahr
- (2014) Andrew J. Lees et al. MOVEMENT DISORDERS
- Improving cognition in schizophrenia with antipsychotics that elicit neurogenesis through 5-HT1A receptor activation
- (2014) Rudy Schreiber et al. NEUROBIOLOGY OF LEARNING AND MEMORY
- Dopaminergic Modulation of Cortical Plasticity in Alzheimer’s Disease Patients
- (2014) Giacomo Koch et al. NEUROPSYCHOPHARMACOLOGY
- Update on the pharmacology of selective inhibitors of MAO-A and MAO-B: Focus on modulation of CNS monoamine neurotransmitter release
- (2014) John P.M. Finberg PHARMACOLOGY & THERAPEUTICS
- Satiety factor oleoylethanolamide recruits the brain histaminergic system to inhibit food intake
- (2014) G. Provensi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer’s disease: design, synthesis, biochemical evaluation, ADMET, molecular modeling, and QSAR analysis of novel donepezil-pyridyl hybrids
- (2014) José Marco-Contelles et al. Drug Design Development and Therapy
- L-dopa-induced dyskinesia: beyond an excessive dopamine tone in the striatum
- (2014) Gregory Porras et al. Scientific Reports
- “Is dopamine involved in Alzheimer's disease?â€
- (2014) Alessandro Martorana et al. Frontiers in Aging Neuroscience
- Alzheimer’s disease and CADASIL are heritable, adult-onset dementias that both involve damaged small blood vessels
- (2013) Vincent T. Marchesi CELLULAR AND MOLECULAR LIFE SCIENCES
- Inhibitor Design for Monoamine Oxidases
- (2013) Rona R. Ramsay CURRENT PHARMACEUTICAL DESIGN
- Non-dopaminergic Treatments for Motor Control in Parkinson’s Disease
- (2013) Susan H. Fox DRUGS
- Cariprazine: chemistry, pharmacodynamics, pharmacokinetics, and metabolism, clinical efficacy, safety, and tolerability
- (2013) Leslie Citrome Expert Opinion on Drug Metabolism & Toxicology
- Second-generation antipsychotics in the treatment of major depressive disorder: current evidence
- (2013) Changsu Han et al. Expert Review of Neurotherapeutics
- Lorcaserin and pimavanserin: emerging selectivity of serotonin receptor subtype–targeted drugs
- (2013) Herbert Y. Meltzer et al. JOURNAL OF CLINICAL INVESTIGATION
- Study of the antidyskinetic effect of eltoprazine in animal models of levodopa-induced dyskinesia
- (2013) Erwan Bezard et al. MOVEMENT DISORDERS
- Addiction as a stress surfeit disorder
- (2013) George F. Koob et al. NEUROPHARMACOLOGY
- Rapid Anxiolytic Effects of a 5-HT4 Receptor Agonist Are Mediated by a Neurogenesis-Independent Mechanism
- (2013) Indira Mendez-David et al. NEUROPSYCHOPHARMACOLOGY
- Monoamines tissue content analysis reveals restricted and site-specific correlations in brain regions involved in cognition
- (2013) A. Fitoussi et al. NEUROSCIENCE
- Ascending monoaminergic systems alterations in Alzheimer's disease. Translating basic science into clinical care
- (2013) Ludwig Trillo et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Memantine and Cholinesterase Inhibitors: Complementary Mechanisms in the Treatment of Alzheimer’s Disease
- (2013) Chris G. Parsons et al. NEUROTOXICITY RESEARCH
- Catechol-O-Methyltransferase (COMT) Protein Expression and Activity after Dopaminergic and Noradrenergic Lesions of the Rat Brain
- (2013) Nadia Schendzielorz et al. PLoS One
- Comparative Efficacy and Acceptability of Antidepressants in Parkinson's Disease: A Network Meta-Analysis
- (2013) Jinling Liu et al. PLoS One
- Genotype-independent decrease in plasma dopamine beta-hydroxylase activity in Alzheimer's disease
- (2013) Maja Mustapic et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Monoamine neurocircuitry in depression and strategies for new treatments
- (2013) Michel Hamon et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- 5-HT systems: emergent targets for memory formation and memory alterations
- (2013) Alfredo Meneses REVIEWS IN THE NEUROSCIENCES
- Glia and epilepsy: excitability and inflammation
- (2013) Orrin Devinsky et al. TRENDS IN NEUROSCIENCES
- Multiple controls exerted by 5-HT2C receptors upon basal ganglia function: from physiology to pathophysiology
- (2013) P. De Deurwaerdère et al. EXPERIMENTAL BRAIN RESEARCH
- Imaging of Dopamine in PD and Implications for Motor and Neuropsychiatric Manifestations of PD
- (2013) Raúl de la Fuente-Fernández Frontiers in Neurology
- Antidepressant therapy in epilepsy: can treating the comorbidities affect the underlying disorder?
- (2012) L Cardamone et al. BRITISH JOURNAL OF PHARMACOLOGY
- Impact of 5-HT3 receptor antagonists on peripheral and central diseases
- (2012) Gohar Fakhfouri et al. DRUG DISCOVERY TODAY
- Axon degeneration in Parkinson's disease
- (2012) Robert E. Burke et al. EXPERIMENTAL NEUROLOGY
- Antidepressant efficacy of agomelatine versus SSRI/SNRI
- (2012) Siegfried Kasper et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Combining Galantamine and Memantine in Multitargeted, New Chemical Entities Potentially Useful in Alzheimer’s Disease
- (2012) Elena Simoni et al. JOURNAL OF MEDICINAL CHEMISTRY
- Contribution of Serotonergic Transmission to the Motor and Cognitive Effects of High-Frequency Stimulation of the Subthalamic Nucleus or Levodopa in Parkinson’s Disease
- (2012) Sylvia Navailles et al. MOLECULAR NEUROBIOLOGY
- l-dopa-induced dopamine synthesis and oxidative stress in serotonergic cells
- (2012) Branden J. Stansley et al. NEUROPHARMACOLOGY
- Serotonin receptors involved in antidepressant effects
- (2012) Francesc Artigas PHARMACOLOGY & THERAPEUTICS
- Reducing antipsychotic-induced weight gain in schizophrenia: a double-blind placebo-controlled study of reboxetine–betahistine combination
- (2012) Michael Poyurovsky et al. PSYCHOPHARMACOLOGY
- Chemical properties of antiepileptic drugs (AEDs)
- (2011) Meir Bialer ADVANCED DRUG DELIVERY REVIEWS
- VAP-1/SSAO Plasma Activity and Brain Expression in Human Hemorrhagic Stroke
- (2011) Mar Hernandez-Guillamon et al. CEREBROVASCULAR DISEASES
- Role of Serotonin in Alzheimerʼs Disease
- (2011) Werner J. Geldenhuys et al. CNS DRUGS
- A Step Further Towards Multitarget Drugs for Alzheimer and Neuronal Vascular Diseases: Targeting the Cholinergic System, Amyloid-β Aggregation and Ca2++ Dyshomeostasis
- (2011) R. Leon et al. CURRENT MEDICINAL CHEMISTRY
- The role of serotonin receptors in the action of atypical antipsychotic drugs
- (2011) HY Meltzer et al. CURRENT OPINION IN PHARMACOLOGY
- Neurovascular dysfunction, inflammation and endothelial activation: Implications for the pathogenesis of Alzheimer's disease
- (2011) Paula Grammas Journal of Neuroinflammation
- Simultaneous determination of catecholamines and their metabolites related to Alzheimer's disease in human urine
- (2011) Lili Liu et al. JOURNAL OF SEPARATION SCIENCE
- A double-blind, delayed-start trial of rasagiline in Parkinson's disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomes
- (2011) Olivier Rascol et al. LANCET NEUROLOGY
- A tale on animal models of Parkinson's disease
- (2011) Erwan Bezard et al. MOVEMENT DISORDERS
- The immunology of stroke: from mechanisms to translation
- (2011) Costantino Iadecola et al. NATURE MEDICINE
- The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics
- (2011) Eric Karran et al. NATURE REVIEWS DRUG DISCOVERY
- The noradrenaline precursor L-DOPS reduces pathology in a mouse model of Alzheimer's disease
- (2011) Sergey Kalinin et al. NEUROBIOLOGY OF AGING
- Emerging dysfunctions consequent to combined monoaminergic depletions in parkinsonism
- (2011) Claire Delaville et al. NEUROBIOLOGY OF DISEASE
- The Physiology, Signaling, and Pharmacology of Dopamine Receptors
- (2011) J.-M. Beaulieu et al. PHARMACOLOGICAL REVIEWS
- Serotonin signaling is associated with lower amyloid- levels and plaques in transgenic mice and humans
- (2011) J. R. Cirrito et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mode of action of agomelatine: Synergy between melatonergic and 5-HT2Creceptors
- (2011) Giorgio Racagni et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Imbalanced Dopaminergic Transmission Mediated by Serotonergic Neurons in L-DOPA-Induced Dyskinesia
- (2011) Sylvia Navailles et al. Parkinsons Disease
- MAO-inhibitors in Parkinson's Disease
- (2011) Peter Riederer et al. Experimental Neurobiology
- The pathological process underlying Alzheimer’s disease in individuals under thirty
- (2010) Heiko Braak et al. ACTA NEUROPATHOLOGICA
- The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia
- (2010) Costantino Iadecola ACTA NEUROPATHOLOGICA
- Cardiovascular Risk-Benefit Profile of Sibutramine
- (2010) A.J. Scheen American Journal of Cardiovascular Drugs
- Apomorphine treatment in Alzheimer mice promoting amyloid-β degradation
- (2010) Eri Himeno et al. ANNALS OF NEUROLOGY
- Deep Brain Stimulation for Parkinson Disease
- (2010) Jeff M. Bronstein et al. ARCHIVES OF NEUROLOGY
- The dopamine β-hydroxylase -1021C/T polymorphism is associated with the risk of Alzheimer's disease in the Epistasis Project
- (2010) Onofre Combarros et al. BMC Medical Genetics
- Replacing a Dopamine Agonist by the COMT-Inhibitor Tolcapone as an Adjunct to l-dopa in the Treatment of Parkinson's Disease
- (2010) Vincent Ries et al. CLINICAL NEUROPHARMACOLOGY
- Neuroprotection in Parkinson's Disease: a Realistic Goal?
- (2010) Salvatore Galati et al. CNS Neuroscience & Therapeutics
- The melatonergic agonist and clinically active antidepressant, agomelatine, is a neutral antagonist at 5-HT2C receptors
- (2010) Mark J. Millan et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Entacapone and Tolcapone, Two CatecholO-Methyltransferase Inhibitors, Block Fibril Formation of α-Synuclein and β-Amyloid and Protect against Amyloid-induced Toxicity
- (2010) Saviana Di Giovanni et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Interactions of Monoamine Oxidases with the Antiepileptic Drug Zonisamide: Specificity of Inhibition and Structure of the Human Monoamine Oxidase B Complex
- (2010) Claudia Binda et al. JOURNAL OF MEDICINAL CHEMISTRY
- Distribution of catechol-O-methyltransferase (COMT) proteins and enzymatic activities in wild-type and soluble COMT deficient mice
- (2010) Timo T. Myöhänen et al. JOURNAL OF NEUROCHEMISTRY
- Effects of Betahistine at Histamine H3 Receptors: Mixed Inverse Agonism/Agonism In Vitro and Partial Inverse Agonism In Vivo
- (2010) F. Gbahou et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Cariprazine (RGH-188), a Dopamine D3 Receptor-Preferring, D3/D2 Dopamine Receptor Antagonist-Partial Agonist Antipsychotic Candidate: In Vitro and Neurochemical Profile
- (2010) B. Kiss et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Vesicular monoamine transporters: Structure-function, pharmacology, and medicinal chemistry
- (2010) Kandatege Wimalasena MEDICINAL RESEARCH REVIEWS
- Amyloid-β and tau — a toxic pas de deux in Alzheimer's disease
- (2010) Lars M. Ittner et al. NATURE REVIEWS NEUROSCIENCE
- Loss of serotonin 2A receptors exceeds loss of serotonergic projections in early Alzheimer's disease: a combined [11C]DASB and [18F]altanserin-PET study
- (2010) Lisbeth Marner et al. NEUROBIOLOGY OF AGING
- Serotonergic neurons mediate ectopic release of dopamine induced by l-DOPA in a rat model of Parkinson's disease
- (2010) Sylvia Navailles et al. NEUROBIOLOGY OF DISEASE
- Chronic L-DOPA therapy alters central serotonergic function and L-DOPA-induced dopamine release in a region-dependent manner in a rat model of Parkinson's disease
- (2010) Sylvia Navailles et al. NEUROBIOLOGY OF DISEASE
- Validation crisis in animal models of drug addiction: Beyond non-disordered drug use toward drug addiction
- (2010) Serge H. Ahmed NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Association of Prescription H1 Antihistamine Use With Obesity: Results From the National Health and Nutrition Examination Survey
- (2010) Joseph C. Ratliff et al. Obesity
- From the cell to the clinic: A comparative review of the partial D2/D3 receptor agonist and α2-adrenoceptor antagonist, piribedil, in the treatment of Parkinson's disease
- (2010) Mark J. Millan PHARMACOLOGY & THERAPEUTICS
- Locus ceruleus controls Alzheimer's disease pathology by modulating microglial functions through norepinephrine
- (2010) M. T. Heneka et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effect of S-COMT deficiency on behavior and extracellular brain dopamine concentrations in mice
- (2010) Anne Tammimäki et al. PSYCHOPHARMACOLOGY
- Functional topography of midbrain and pontine serotonergic systems: implications for synaptic regulation of serotonergic circuits
- (2010) Matthew W. Hale et al. PSYCHOPHARMACOLOGY
- Plasma VAP-1/SSAO Activity Predicts Intracranial Hemorrhages and Adverse Neurological Outcome After Tissue Plasminogen Activator Treatment in Stroke
- (2010) Mar Hernandez-Guillamon et al. STROKE
- Monoaminergic Neurotransmission: The History of the Discovery of Antidepressants from 1950s Until Today
- (2009) Francisco Lopez-Munoz et al. CURRENT PHARMACEUTICAL DESIGN
- Extended-Release Quetiapine as Adjunct to an Antidepressant in Patients With Major Depressive Disorder
- (2009) Michael Bauer et al. JOURNAL OF CLINICAL PSYCHIATRY
- Half a Century of Antidepressant Drugs
- (2009) Peter Fangmann et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Long-term effects of the concomitant use of memantine with cholinesterase inhibition in Alzheimer disease
- (2009) O L Lopez et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis
- (2009) Andrea Cipriani et al. LANCET
- The scientific and clinical basis for the treatment of Parkinson disease (2009)
- (2009) C. W. Olanow et al. NEUROLOGY
- The locus ceruleus norepinephrine system: Functional organization and potential clinical significance
- (2009) E. E. Benarroch NEUROLOGY
- Dopamine Modulates Cholinergic Cortical Excitability in Alzheimer's Disease Patients
- (2009) Alessandro Martorana et al. NEUROPSYCHOPHARMACOLOGY
- Pimavanserin, a Serotonin2A Receptor Inverse Agonist, for the Treatment of Parkinson's Disease Psychosis
- (2009) Herbert Y Meltzer et al. NEUROPSYCHOPHARMACOLOGY
- Platelet serotonin concentration and monoamine oxidase type B activity in female patients in early, middle and late phase of Alzheimer's disease
- (2009) Dorotea Muck-Seler et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- p53 phosphorylation is involved in vascular cell death induced by the catalytic activity of membrane-bound SSAO/VAP-1
- (2008) Montse Solé et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Agomelatine: A novel mechanism of antidepressant action involving the melatonergic and the serotonergic system
- (2008) Luis San et al. EUROPEAN PSYCHIATRY
- Effect of histaminergic manipulation on weight in obese adults: a randomized placebo controlled trial
- (2008) N Barak et al. INTERNATIONAL JOURNAL OF OBESITY
- Anti-apoptotic effect of Mao-B inhibitor PF9601N [N-(2-propynyl)-2-(5-benzyloxy-indolyl) methylamine] is mediated by p53 pathway inhibition in MPP+-treated SH-SY5Y human dopaminergic cells
- (2008) Elisenda Sanz et al. JOURNAL OF NEUROCHEMISTRY
- The up-regulation of BACE1 mediated by hypoxia and ischemic injury: role of oxidative stress and HIF1α
- (2008) Michela Guglielmotto et al. JOURNAL OF NEUROCHEMISTRY
- Dopamine D3 receptor stimulation underlies the development of L-DOPA-induced dyskinesia in animal models of Parkinson's disease
- (2008) Naomi P. Visanji et al. NEUROBIOLOGY OF DISEASE
- New therapeutic targets in the neurovascular pathway in Alzheimer’s disease
- (2008) Berislav V. Zlokovic Neurotherapeutics
- Unfaithful neurotransmitter transporters: Focus on serotonin uptake and implications for antidepressant efficacy
- (2008) Lynette C. Daws PHARMACOLOGY & THERAPEUTICS
- Neurobiological mechanisms for opponent motivational processes in addiction
- (2008) G. F Koob et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Effect of R3487/MEM3454, a novel nicotinic α7 receptor partial agonist and 5-HT3 antagonist on sustained attention in rats
- (2008) Amir H. Rezvani et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Psychiatric Comorbidities and Schizophrenia
- (2008) P. F. Buckley et al. SCHIZOPHRENIA BULLETIN
- VAP-1 and CD73, Endothelial Cell Surface Enzymes in Leukocyte Extravasation
- (2007) Sirpa Jalkanen et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Cognitive dysfunction in neuropsychiatric disorders: Selected serotonin receptor subtypes as therapeutic targets
- (2007) Alvin V. Terry et al. BEHAVIOURAL BRAIN RESEARCH
- Early disruptions of the blood–brain barrier may contribute to exacerbated neuronal damage and prolonged functional recovery following stroke in aged rats
- (2007) Vincent A. DiNapoli et al. NEUROBIOLOGY OF AGING
- Vascular adhesion protein-1 in human ischaemic stroke
- (2007) L. Airas et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation